Daniel L. Dexter
Impact in
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Oncology top 2%
- Cancer Cells and Metastasis
Papers in
-
- Biochemical and Molecular Research 10
- Cancer therapeutics and mechanisms 10
- Oncology 31
- Cancer Cells and Metastasis 11
- Pancreatic and Hepatic Oncology Research 6
- Colorectal Cancer Treatments and Studies 6
- Cancer Treatment and Pharmacology 5
- Co-authors
- Paul Calabresi (20 shared papers)John T. Leith (15 shared papers)Ellen N. Spremulli (11 shared papers)Gloria H. Heppner (2 shared papers)J A Barbosa (3 shared papers)Zuzana Fligiel (3 shared papers)Beverly A. Blazar (1 shared paper)Shih-Fong Chen (6 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (5 papers)Cancer Chemotherapy and Pharmacology (5 papers)Biochemical Pharmacology (5 papers)JNCI Journal of the National Cancer Institute (4 papers)Cancer (3 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Daniel L. Dexter
85 papers receiving 3.7k citations
Daniel L. Dexter's Hit Papers
Peers
Comparison fields: 5 of 137
- Cancer Research 1.1k
- Oncology 1.4k
- Biotechnology 290
- Molecular Biology 2.0k
- Modeling and Simulation 114
Countries citing papers authored by Daniel L. Dexter
This map shows the geographic impact of Daniel L. Dexter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Dexter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Dexter more than expected).
Fields of papers citing papers by Daniel L. Dexter
This network shows the impact of papers produced by Daniel L. Dexter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Dexter. The network helps show where Daniel L. Dexter may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel L. Dexter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Heterogeneity of tumor cells from a single mouse mammary tumor. Hit paper breakdown → | 1978 | 471 |
| 2 | N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. Hit paper breakdown → | 1979 | 239 |
| 3 | 1990 | 234 | |
| 4 | Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor. | 1978 | 231 |
| 5 | 1986 | 177 | |
| 6 | 1981 | 139 | |
| 7 | Mechanism of action of the novel anticancer agent 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarbo xylic acid sodium salt (NSC 368390): inhibition of de novo pyrimidine nucleotide biosynthesis. | 1986 | 128 |
| 8 | Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor. | 1999 | 121 |
| 9 | 1979 | 96 | |
| 10 | 1997 | 95 | |
| 11 | Preclinical antitumor activity of 6-hydroxymethylacylfulvene, a semisynthetic derivative of the mushroom toxin illudin S. | 1997 | 92 |
| 12 | 1997 | 91 | |
| 13 | 1984 | 89 | |
| 14 | 1993 | 88 | |
| 15 | Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line. | 1990 | 87 |
| 16 | 1983 | 81 | |
| 17 | Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate. | 1988 | 81 |
| 18 | Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarb oxylic acid sodium salt], against experimental tumors. | 1985 | 80 |
| 19 | 1982 | 69 | |
| 20 | The clinical pharmacology of 5-trifluoromethyl-2'-deoxyuridine. | 1972 | 65 |
About Daniel L. Dexter
Daniel L. Dexter is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 86 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (14 papers), Cancer Cells and Metastasis (11 papers), Biochemical and Molecular Research (10 papers), Cancer therapeutics and mechanisms (10 papers), Pancreatic and Hepatic Oncology Research (6 papers), Cancer Research and Treatments (6 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.4k citations), Biotechnology (290 citations), Molecular Biology (2.0k citations) and Modeling and Simulation (114 citations). Daniel L. Dexter has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Paul Calabresi, John T. Leith, Ellen N. Spremulli, Gloria H. Heppner, J A Barbosa, Zuzana Fligiel, Beverly A. Blazar, Shih-Fong Chen, Betsy A. Dusak and Peter A. Calabresi. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Cancer Chemotherapy and Pharmacology, Biochemical Pharmacology, JNCI Journal of the National Cancer Institute and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.